Litcius/Paper detail

Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma

Jianyi Yin, Roy Elias, Lan Peng, Nicholas Levonyak, Annapoorani Asokan, Alana Christie, Nisa Kubiliun, James Brugarolas, Hans J. Hammers

2022Clinical Genitourinary Cancer21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRenal cell carcinomaProton-pump inhibitorImmune checkpointColitisInternal medicineOncologyImmune systemCancer researchCancerImmunotherapyImmunologyCancer Immunotherapy and BiomarkersRenal cell carcinoma treatmentMicroscopic Colitis
Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell Carcinoma | Litcius